CDXC
(CDXC) trades at $7.85 as of 7:53:29 PM EDT on Mar 18, 2025, with 1.0 days to cover in short interest.
Key statistics
Today's trading snapshot for CDXC: day range, open, previous close, volume and market cap.
- Day range
- $7.75 – $7.92
- Open
- $7.91
- Prev close
- —
- Volume
- 541.87K
- Market cap
- —
- Shares out
- —
8-K filings
Material corporate events has disclosed to the SEC on Form 8-K.
- Quarterly earningsNov 4, 2026
On November 4, 2026, Niagen Bioscience, Inc. (the "Company") issued a press release announcing its earnings for the quarter ended September 30, 2026.
- Investor presentationAug 4, 2026
On August 4, 2026, the Company released a corporate presentation which it made available on its website.
- Annual meeting resultsJun 29, 2026
Set forth below are the results of the matters submitted for a vote of stockholders at the Company's 2026 Annual Meeting. Proposal 1 — Election of directors. The following directors were elected to serve until the Company's 2027 Annual Meeting of Stockholders...
- Investor presentationMay 6, 2026
On May 6, 2026, the Company released a corporate presentation which it made available on its website.
- Share repurchase programMar 19, 2026
the Board of Directors (the "Board") of Niagen Bioscience, Inc. (the "Company") approved an increase in the authorization under the Company's share repurchase program. Under the amended authorization, the Company may repurchase up to $20.0 million of its outstanding common stock, representing an increase from the previously authorized $10.0 million share repurchase program approved by the Board on October 31, 2025.
Dividend history and stock splits
's recent dividend payments and stock splits.
Dividends
No recent dividends.
Splits
- 1-for-3Apr 13, 2016
CDXC short interest
How heavily CDXC is shorted: shares short, days to cover and average daily volume.
- Days to cover
- 1.0
- Short interest
- 1.89M
- Avg volume
- 2.86M
As of · reported to FINRA twice monthly.
CDXC news
The latest news and headlines about (CDXC).
- Chlorinated Isopropane Market Set for 4.9% CAGR Growth, Hitting USD 496.0 Million by 2035 | Fact.MR ReportneutralGlobeNewswire Inc.· Mar 19, 2025
- ChromaDex (CDXC) Up as Ataxia Candidate Gets Orphan Drug TagZacks Investment Research· Jun 10, 2024
- Precision BioSciences (DTIL) Soars 13.4%: Is Further Upside Left in the Stock?Zacks Investment Research· Apr 2, 2024
- Kiniksa Pharmaceuticals, Ltd. (KNSA) Q4 Earnings and Revenues Surpass EstimatesZacks Investment Research· Feb 28, 2024
- ChromaDex (CDXC) Reports Q2 Loss, Tops Revenue EstimatesZacks Investment Research· Aug 9, 2023
Frequently asked questions
What is the (CDXC) stock price today?
(CDXC) is trading at $7.85 as of 7:53:29 PM EDT on Mar 18, 2025. Prices are delayed at least 15 minutes; real-time quotes are available from the Massive API.
What is ?
(CDXC) is a security listed on a US exchange.
What is the short interest in CDXC?
As of Mar 14, 2025, CDXC has 1.89M shares short and 1.0 days to cover.
Build with AI
Build an analysis of CDXC with your agent
Point Claude or ChatGPT at the Massive MCP server and recreate this page from live data.
Connect the Massive MCP server (API reference: massive.com/docs/llms.txt) and build a CDXC analysis: the latest quote, key ratios (P/E, P/S, ROE), short interest, recent insider activity and the latest news.
Nothing on this page is investment advice. All data and content is provided for informational purposes under our Terms of Service.